Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, May 10 2024

Full Issue

Longer Looks: Interesting Reads You Might Have Missed

Each week, KFF Health News finds longer stories for you to enjoy. This week's selections include stories on weight loss, syphilis, mental health, lead poisoning, and more.

The Wall Street Journal: The Quest For Treatments To Keep Weight Off After Ozempic 

Drugs or procedures to keep weight off could fuel an even bigger bonanza than Ozempic and its immensely profitable cousins. Losing weight is temporary, but maintaining it is lifelong. Maintaining weight is also a different challenge from losing it. (McKay, 5/8)

ProPublica: This School for Autistic Youth Can Cost $573,200 a Year. It Operates With Little Oversight, and Students Have Suffered

No state agency has authority over Shrub Oak, one of the country's most expensive therapeutic boarding schools. As a result, parents and staff have nowhere to report bruised students and medication mix-ups. (Smith Richards and Cohen, 5/8)

The New York Times: When Prison and Mental Illness Amount to a Death Sentence

Markus Johnson slumped naked against the wall of his cell, skin flecked with pepper spray, his face a mask of puzzlement, exhaustion and resignation. Four men in black tactical gear pinned him, his face to the concrete, to cuff his hands behind his back. He did not resist. He couldn’t. He was so gravely dehydrated he would be dead by their next shift change. “I didn’t do anything,” Mr. Johnson moaned as they pressed a shield between his shoulders. (Thrush, 5/5)

ProPublica: Facing Unchecked Syphilis Outbreak, Great Plains Tribes Sought Federal Help. Months Later, No One Has Responded

The syphilis rate among Indigenous people in the Great Plains is higher than at any point in 80 years of records. More than 3% of Native American babies born in South Dakota last year had the preventable and curable — but potentially fatal — disease. (Barry-Jester, 5/7)

The New York Times: Lead In Beethoven’s Hair Offers New Clues To Mystery Of His Deafness 

Using powerful technologies, scientists found staggering amounts of lead and other toxic substances in the composer’s hair that may have come from wine, or other sources. High doses of lead affect the nervous system, and could have destroyed his hearing. (Kolata, 5/6)

The Washington Post: The Children Who Remember Their Past Lives

In the beginning, it seemed like Nina was just an imaginary friend. Two-year-old Aija had invented plenty of fictional characters before, but her parents — Ross, a musician, and Marie, a psychologist — noticed right away that Nina was different. From the time Aija learned how to talk, she talked about Nina, and her descriptions were remarkably consistent. Aija told her parents that Nina played piano, and she loved dancing, and she favored the color pink (Aija emphatically did not). When Aija spoke as Nina, in the first person, Aija’s demeanor changed: Her voice was sweeter and higher-pitched, her affect more gentle and polite than what Marie and Ross typically expected from their rambunctious toddler. (Gibson, 5/2)

The Wall Street Journal: A Lawyer’s Slide Into Psychosis Was Captured In A WSJ Profile. He Tells Us His Story

Rob Dart isn’t the successful lawyer and father who left the people who love him two years ago to follow his delusions. That Rob lives in the memory of friends and in family photos. This Rob, who arrives on time for our interview, is standing by the roadside under the blazing California sun, his eyes and hair competing in wildness, his grin difficult not to match. In the past year, this Rob has been hospitalized, shot, housed, unhoused, a winner and a loser in court battles. Ultimately, he has shed every scrap of evidence of his life before illness: his connections to his son, family and most friends. (Wernau, 5/4)

North Carolina Health News: Using Nature To Treat Mental Health Patients 

Psychiatrist Nora Dennis works to build a care farm where people with mental illness can be healed as they nurture plants and animals.(Hoban, 5/8)

The New York Times: How Bad Are Ultraprocessed Foods, Really? 

They’re clearly linked to poor health. But scientists are only beginning to understand why. (Callahan, 5/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF